Key result
HDAC6 knockout exacerbates PM2.5-induced pulmonary injury in mice by reducing ACE2 and elevating Ang II.
Why the study?
PM 2.5 deposition induces pulmonary injury and HDAC6 regulates lung diseases, but the mechanism of HDAC6 in PM 2.5-induced pulmonary injury remained unclear.
HDAC6 knockout exacerbates PM 2.5-induced pulmonary injury in mice by disrupting the renin-angiotensin system balance.
Fine particulate matter (PM 2.5 ) deposition in the lungs can induce pulmonary injury. Histone deacetylase 6 (HDAC6), a critical member of the histone deacetylase family, plays a key role in regulating lung diseases. In this study, we explored the mechanism of HDAC6 in PM 2.5 (10 mg/kg)–induced pulmonary injury using an HDAC6 knockout (KO) mouse model, employing immunohistochemical, western blot, and transcriptome analyses. Results indicated that HDAC6 KO exacerbated PM 2.5 -induced epithelial barrier dysfunction by altering the expression of zonula occludens-1 (ZO-1) and zonula occludens-2 (ZO-2). Moreover, HDAC6 KO increased the susceptibility of lung tissue to PM 2.5 by inhibiting E-cadherin expression and promoting N-cadherin expression. Transcriptome analysis of PM 2.5 -treated lungs in the HDAC6 KO group revealed significant alterations in the renin-angiotensin system (RAS). The expression levels of RAS components, including angiotensin-converting enzyme II (ACE2), angiotensin II (Ang II), renin, and Agtrl1b, were quantified. Notably, both PM 2.5 and HDAC6 KO disrupted RAS balance. The PM 2.5 -treated HDAC6 KO group exhibited a pronounced reduction in ACE2 and elevation in Ang II, suggesting increased susceptibility to PM 2.5 . These results indicate that HDAC6 KO exacerbates PM 2.5 -induced pulmonary injury by affecting RAS balance. This study provides a theoretical foundation for understanding the role of HDAC 6 in PM 2.5 -induced pulmonary injury.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question. HDAC6 knockout exacerbates PM2.5-induced pulmonary injury in mice by disrupting the renin-angiotensin system balance, specifically by reducing ACE2 and elevating Ang II.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: